Provectus Biopharmaceuticals, Inc. lèt majiskil
Provectus Biopharmaceuticals, Inc. majiskil an dola jodi an. Provectus Biopharmaceuticals, Inc. lèt majiskil sou mache a se sòm tout Provectus Biopharmaceuticals, Inc. ki soti. Provectus Biopharmaceuticals, Inc. lèt majiskil pou jodi a sou sit entènèt nou an pou referans. Provectus Biopharmaceuticals, Inc. majiskil = 56 575 912 dola ameriken.
Provectus Biopharmaceuticals, Inc. volim nan komès
Provectus Biopharmaceuticals, Inc. volim komès jodi a - 100 200 dola ameriken. Provectus Biopharmaceuticals, Inc. te komèsyal nan plizyè sit entènèt komès yo. Provectus Biopharmaceuticals, Inc. komès nan tan reyèl hands sou pi echanj valè stock, sit entènèt nou an montre volim komès la chak jou nan Provectus Biopharmaceuticals, Inc.. Provectus Biopharmaceuticals, Inc. mache kap ogmante pa $ 4 732 488.
|
Provectus Biopharmaceuticals, Inc. mache bouchon tablo
Provectus Biopharmaceuticals, Inc. mache kap kap tablo pa ane. Sou semèn lan, Provectus Biopharmaceuticals, Inc. majiskil chanje pa -1.96%. Provectus Biopharmaceuticals, Inc. chanjman majiskil pou ane a se 1.01%. Provectus Biopharmaceuticals, Inc. majiskil ap grandi chak jou nan dola ameriken.
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Provectus Biopharmaceuticals, Inc. Istwa kapitalizasyon
| Dat |
Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
|
|---|---|
| 04/05/2023 | 56 575 912 $ |
| 03/05/2023 | 51 843 424 $ |
| 02/05/2023 | 56 324 184 $ |
| 01/05/2023 | 60 372 816 $ |
| 28/04/2023 | 56 009 524 $ |
| 27/04/2023 | 57 100 344 $ |
| 26/04/2023 | 57 708 688 $ |
Provectus Biopharmaceuticals, Inc. tablo volim
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Provectus Biopharmaceuticals, Inc. done istwa volim
| Dat |
Volim (24h)
Volim komèsyal de aksyon Provectus Biopharmaceuticals, Inc. se kantite total tout tranzaksyon ak aksyon PVCT achte ak vann pandan dat la chwazi a.
|
|---|---|
| 04/05/2023 | 100 200 $ |
| 03/05/2023 | 181 515 $ |
| 02/05/2023 | 48 157 $ |
| 01/05/2023 | 85 652 $ |
| 28/04/2023 | 193 782 $ |
| 27/04/2023 | 56 585 $ |
| 26/04/2023 | 97 404 $ |
Provectus Biopharmaceuticals, Inc. lèt majiskil sou mache a se $ 56 575 912 nan 04/05/2023. Provectus Biopharmaceuticals, Inc. majiskil nan 03/05/2023 montan pou 51 843 424 dola ameriken. Lèt majiskil sou mache Provectus Biopharmaceuticals, Inc. nan 02/05/2023 montan pou 56 324 184 dola ameriken. Provectus Biopharmaceuticals, Inc. majiskil egal a 60 372 816 dola ameriken nan 01/05/2023.
28/04/2023 Provectus Biopharmaceuticals, Inc. majiskil egal a 56 009 524 dola ameriken. Provectus Biopharmaceuticals, Inc. majiskil nan 27/04/2023 egal a 57 100 344 dola ameriken. Lèt majiskil sou mache Provectus Biopharmaceuticals, Inc. nan 26/04/2023 montan pou 57 708 688 dola ameriken.
Lèt majiskil Provectus Biopharmaceuticals, Inc. jodi a se 56 575 912 $. Kapitalizasyon sou mache a nan Provectus Biopharmaceuticals, Inc. te chanje a +9.13% konpare ak yè. Volim komèsyal de aksyon PVCT nan Provectus Biopharmaceuticals, Inc. nan dènye jou komès montan pou 100 200 $. Volim komèsyal de aksyon de Provectus Biopharmaceuticals, Inc. chanje pou -44.798% konpare ak jou komès anvan an.